BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24833664)

  • 1. Neural autoantibody clusters aid diagnosis of cancer.
    Horta ES; Lennon VA; Lachance DH; Jenkins SM; Smith CY; McKeon A; Klein C; Pittock SJ
    Clin Cancer Res; 2014 Jul; 20(14):3862-9. PubMed ID: 24833664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody profiles and neurological correlations of thymoma.
    Vernino S; Lennon VA
    Clin Cancer Res; 2004 Nov; 10(21):7270-5. PubMed ID: 15534101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.
    Zekeridou A; McKeon A; Lennon VA
    JAMA Neurol; 2016 Jul; 73(7):853-9. PubMed ID: 27135398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.
    Pittock SJ; Kryzer TJ; Lennon VA
    Ann Neurol; 2004 Nov; 56(5):715-9. PubMed ID: 15468074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
    Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
    Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm.
    Shelly S; Paul P; Bi H; Dubey D; Milone M; Sorenson EJ; Crum BA; Laughlin RS; Liewluck T; Mandrekar J; Pittock SJ; Zekeridou A; McKeon A; Harper MC; Mills JR; Klein CJ
    Neurology; 2020 Dec; 95(22):e3002-e3011. PubMed ID: 32938782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
    Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
    Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.
    Pittock SJ; Lucchinetti CF; Lennon VA
    Ann Neurol; 2003 May; 53(5):580-7. PubMed ID: 12730991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
    Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
    J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
    Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
    Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.
    Yu Z; Kryzer TJ; Griesmann GE; Kim K; Benarroch EE; Lennon VA
    Ann Neurol; 2001 Feb; 49(2):146-54. PubMed ID: 11220734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
    Zekeridou A; Majed M; Heliopoulos I; Lennon VA
    Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic autoimmune neurologic disorders associated with thymoma.
    Iorio R; Lennon VA
    Handb Clin Neurol; 2024; 200():385-396. PubMed ID: 38494291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striational antibodies in a paraneoplastic context.
    McKeon A; Lennon VA; LaChance DH; Klein CJ; Pittock SJ
    Muscle Nerve; 2013 Apr; 47(4):585-7. PubMed ID: 23463255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma.
    Vernino S; Eggenberger ER; Rogers LR; Lennon VA
    Neurology; 2002 Sep; 59(6):929-32. PubMed ID: 12297583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
    Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
    Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative autoantibody profiling before and after appearance of malignance: identification of anti-cathepsin D autoantibody as a promising diagnostic marker for lung cancer.
    Luo X; Lu F; Wang HL; Wang N; Li WH; Guo N; Wang HX; Xia Q
    Biochem Biophys Res Commun; 2012 Apr; 420(4):704-9. PubMed ID: 22310721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.